Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Microbial Pathogenesis
|
February 22, 2002
Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS
J Wayne Conlan, Rhonda KuoLee, Hua Shen, et al.
Vaccine
|
March 10, 2007
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis
Rhonda KuoLee, Greg Harris, J Wayne Conlan, et al.
Microbial Pathogenesis
|
May 4, 2004
Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis
Wangxue Chen, Rhonda KuoLee, Hua Shen, et al.
Vaccine
|
September 26, 2002
Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen
J Wayne Conlan, Hua Shen, Ann Webb, et al.
Vaccine
|
August 19, 2003
Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background
Wangxue Chen, Hua Shen, Ann Webb, et al.
Vaccine
|
March 9, 2005
Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism
J Wayne Conlan, Hua Shen, Rhonda Kuolee, et al.
Microbial Pathogenesis
|
May 7, 2003
Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies
J Wayne Conlan, Wangxue Chen, Hua Shen, et al.
Microbial Pathogenesis
|
March 7, 2003
Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen
J Wayne Conlan, Evguenii Vinogradov, Mario A Monteiro, et al.
Microbial Pathogenesis
|
October 2, 2004
Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis
Wangxue Chen, Rhonda KuoLee, Hua Shen, et al.
Pathogens (Basel, Switzerland)
|
August 26, 2014
Roles for <i>wbtC</i>, <i>wbtI</i>, and <i>kdtA</i> Genes in Lipopolysaccharide Biosynthesis, Protein Glycosylation, Virulence, and Immunogenicity in <i>Francisella tularensis2</i> Strain SCHU S4
Susan M Twine, Evguenii Vinogradov, Helena Lindgren, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Microbial Pathogenesis
|
February 22, 2002
Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS
J Wayne Conlan, Rhonda KuoLee, Hua Shen, et al.
Vaccine
|
March 10, 2007
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis
Rhonda KuoLee, Greg Harris, J Wayne Conlan, et al.
Microbial Pathogenesis
|
May 4, 2004
Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis
Wangxue Chen, Rhonda KuoLee, Hua Shen, et al.
Vaccine
|
September 26, 2002
Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen
J Wayne Conlan, Hua Shen, Ann Webb, et al.
Vaccine
|
August 19, 2003
Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background
Wangxue Chen, Hua Shen, Ann Webb, et al.
Vaccine
|
March 9, 2005
Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism
J Wayne Conlan, Hua Shen, Rhonda Kuolee, et al.
Microbial Pathogenesis
|
May 7, 2003
Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies
J Wayne Conlan, Wangxue Chen, Hua Shen, et al.
Microbial Pathogenesis
|
March 7, 2003
Mice intradermally-inoculated with the intact lipopolysaccharide, but not the lipid A or O-chain, from Francisella tularensis LVS rapidly acquire varying degrees of enhanced resistance against systemic or aerogenic challenge with virulent strains of the pathogen
J Wayne Conlan, Evguenii Vinogradov, Mario A Monteiro, et al.
Microbial Pathogenesis
|
October 2, 2004
Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis
Wangxue Chen, Rhonda KuoLee, Hua Shen, et al.
Pathogens (Basel, Switzerland)
|
August 26, 2014
Roles for <i>wbtC</i>, <i>wbtI</i>, and <i>kdtA</i> Genes in Lipopolysaccharide Biosynthesis, Protein Glycosylation, Virulence, and Immunogenicity in <i>Francisella tularensis2</i> Strain SCHU S4
Susan M Twine, Evguenii Vinogradov, Helena Lindgren, et al.
Page
of 4